Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROOLIFE GROUP LTD Director's Dealing 2021

Dec 1, 2021

65712_rns_2021-12-01_c7a0864e-2959-4c93-b7a1-5088cae24538.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RooLife Group Ltd
ABN 14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director Warren Barry
Date of last notice 1 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Barry Consulting Pty Ltd ATF Barry Family Trust(Mr Barry is a beneficiary of this trust)Barry Family Super Fund (Mr Barry is a memberof the Fund)
Date of change 1 December 2021
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change 24,832,142 Fully Paid Ordinary Shares.8,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject to thefollowing vesting conditions:-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company’s Shares is equal to or greater than$0.055 per share.-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company’s Shares is equal to or greater than$0.08 per share.-3,200,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company’s Shares is equal to or greater than$0.12 per share.-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023
Class Fully Paid Ordinary Shares
Number acquired 493,125
Number disposed -
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.02 per share
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 25,325,267 Fully Paid Ordinary Shares.8,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject to thefollowing vesting conditions:-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company’s Shares is equal to or greater than$0.055 per share.-2,400,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company’s Shares is equal to or greater than$0.08 per share.-3,200,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company’s Shares is equal to or greater than$0.12 per share.-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023
the Companys Shares is equal to or greater t$0.055 per share.-2,400,000: Vesting Condition will be taken to h
-3,200,000: Vesting Condition will be taken to hbeen met if, for any consecutive trading day perbetween the date of the grant of the ExecuOfficer Options and 5 February 2023, the VWAPthe Company’s Shares is equal to or greater t$0.12 per share.-All Executive Officer Options also have a time-ba
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Date of change N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to whichthe interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? No
If so, was prior written clearance provided to allow the trade to proceed duringthis period? N/A
If prior written clearance was provided, on what date was this provided? N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011